NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities


Friday, March 12, 2010
 
MiddleBrook Pharmaceuticals, Inc. Plans Massive Layoffs, CEO Resigns    More...

Pfizer Inc. (PFE) (JOBS) Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer    More...

Pfizer Inc. (PFE) (JOBS) Says Sutent Breast Cancer Trials Fail    More...

Sanofi-Aventis K.K. And Bristol-Myers Squibb Company (BMY) Announce Important Updates to PLAVIX U.S. Prescribing Information; FDA Announces New Boxed Warning on Plavix    More...

Roche Holding AG (RHHBF.PK), Genentech (South SF) (RHHBY)'s Avastin Fails in Prostate Cancer Study    More...

AVEO Pharmaceuticals, Inc. (AVEO) Announces Pricing of Its Initial Public Offering    More...

FDA Approves Eisai Inc. (ESALF.PK)'s Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)    More...

Ipsen Grants Rhythm Pharmaceuticals Obesity Treatment Licence; Ipsen will Receive up to $80 Million    More...

 
More Breaking News


 
 

 Market Summary

 
AstraZeneca PLC (AZN) Boosts Generic Exposure with Torrent Pharmaceuticals Ltd. Deal    More...

Portola Pharmaceuticals, Inc.'s Announces CEO, Charles Homcy, M.D. to Retire    More...

200 Manchester Jobs Under Threat in AstraZeneca PLC (AZN) Cuts    More...

Local Pharma Can And Should Step Up Outsourcing Play    More...

FDA Rules Out Thigh Fracture Link with Bisphosphonate, Including Medications such as Merck & Co., Inc. (MRK)'s Fosamax    More...

BioSante Pharmaceuticals, Inc. (BPAX) Says Leukemia Vaccine Shows Promise in Study    More...

Senetek PLC (SNTK) Embarks on New Strategic Direction; Company Completes $3.0 Million Financing; CEO and CFO Terminated in Connection with Financing    More...

Discovery of 'Fat' Taste Could Hold the Key to Reducing Obesity, Deakin University Study    More...

Abbott Laboratories (ABT) (JOBS) to Buy Facet Biotech (JOBS) for $722 Million    More...

Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) Diabetes Drug Faces Crucial FDA Decision    More...

 
More News

Join the GenePool

     
 
 
 Advanced Search     

 
Platelet-Rich Fibrin Matrix Shows No Impact On Clinical Outcomes, Study At American Academy of Orthopaedic Surgeons Conference Finds    More...
Women On Pill 'May Live Longer', Aberdeen University Study    More...
Breast Cancer Drug Fulvestrant Appears More Effective in the Presence of CK8 and CK18, Indiana University Study    More...
Novel Stroke Treatment Passes Safety Stage of Clinical Trial At University of California, Irvine Study    More...
Movement Disorder Symptoms Are Lessened by an Antibiotic, University of Alabama at Birmingham Study    More...
University of Essex Scientists Make Important Discovery in Gene Regulation    More...
University of Iowa Research Points to Way to Improve Heart Treatment    More...
Calcium May Help You Live Longer, Karolinska Institute Study    More...
 
More Featured News




 
The Boehringer Ingelheim group of companies is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the privately–owned company currently has nearly 39,800 employees and 135 affiliated companies spread around the globe. Boehringer Ingelheim is research-driven and dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products.

Show me jobs for this employer
 
Feature Employer
 
How to Answer 10 Tricky Interview Questions    More...

The Five Most-Asked Interview Questions    More...

How to Give a Good Job Interview: 10-minute Body Language    More...

A Cover Letter Without a Personal Touch is a Deal Breaker    More...

Points of Reference: How to Compile Reference Letters Like a Pro    More...

Best Practices for Professional Use of Social Media    More...

Interns: Job Interview Q & A: How to Make the Best First Impression    More...

Negotiating A Professional Reference Is Just As Important As A Severance Package    More...

Interview Mistakes That Can Cost You The Job    More...

Advice For Two Sticky Job-search Situations    More...

 
More Career Tips